AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus

Key Points:

• AbbVie is investing $1.4 billion to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina, marking its largest-ever capital investment in a single campus and its first major investment in the state.
• The new campus will integrate advanced manufacturing and AI technologies to support production of immunology, neuroscience, and oncology medicines, with construction starting in 2026 and completion expected by the end of 2028.
• The project will create 734 new jobs in engineering, science, manufacturing, and laboratory roles, and generate over 2,000 construction jobs during development, contributing to the local economy.
• This investment is part of AbbVie's broader $100 billion commitment to U.S. research, development, and manufacturing over the next decade, reinforcing its manufacturing footprint and pipeline growth.
• AbbVie currently employs approximately 29,000 people across the U.S. and has recently committed over $2.2 billion to U.S. manufacturing investments, creating more than 1,300 jobs across multiple states.